Skip to search formSkip to main contentSkip to account menu

Amphotericin B Colloidal Dispersion

Known as: AMPHOTERICIN B CHOLESTERYL SULFATE, Amphotericin B Colloidal Dispersion [Chemical/Ingredient] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
SummaryAbstractFormulation of amphotericin B with sodium cholesteryl sulphate alters the pharmacokinetic properties of the drug… 
2006
2006
BACKGROUND In Bihar, India, where visceral leishmaniasis (VL) is hyperendemic and refractory to antimony, amphotericin B is the… 
2005
2005
Background and Aim:  Amphotericin B (AmB) desoxycholate remains as one of the most efficacious agents currently available for the… 
2004
2004
Amphotericin B deoxycholate (AmB) or Amphotericin B colloidal dispersion (ABCD) are used in clinics for the treatment of systemic… 
Review
1999
Review
1999
Amphotericin B is an effective antileishmanial agent whose use is limited by drug toxicity. The development of less toxic, lipid… 
Review
1999
Review
1999
Three published clinical trials of the efficacy of amphotericin B colloidal dispersion (ABCD) against infections caused by… 
Review
1999
Review
1999
Data from five clinical trials of amphotericin B colloidal dispersion (ABCD) in the treatment of invasive mycoses were pooled to… 
Review
1999
Review
1999
Five clinical trials of the efficacy of amphotericin B colloidal dispersion (ABCD) primarily in patients unable to tolerate or… 
Review
1998
Review
1998
PURPOSE/OBJECTIVES To review the drug profile and nursing implications associated with the new lipid amphotericin preparations… 
Review
1998
Review
1998
UNLABELLED Formulation of amphotericin B with sodium cholesteryl sulphate alters the pharmacokinetic properties of the drug…